
AU  - Correnti, Colin
AU  - Strong, Roland K.
C7  - pp. 1-11
TI  - Iron Sequestration in Immunity
UR  - https://doi.org/10.1002/9781119951438.eibc2142
DO  - doi:10.1002/9781119951438.eibc2142
SP  - 1-11
KW  - transferrin
KW  - ferritin
KW  - lactoferrin
KW  - hepcidin
KW  - hemopexin
KW  - haptoglobin
KW  - siderophore
KW  - siderocalin
AB  - Abstract Almost every living thing requires iron (including aerobic, and facultative and obligate anaerobic bacteria) because iron plays key roles in a broad range of physiologically essential molecular processes ranging from catalysis, oxygen transport, and oxidative phosphorylation to structuring proteins. The useful redox properties of iron enable its utility in these molecular functions, but its scarcity in the environment in bioavailable forms, coupled with the double-edged nature of its redox properties (which can lead to the generation of cytotoxic reactive oxygen species), require complicated acquisition, transport, and storage mechanisms, both by environmental microbes and by higher animals. These iron acquisition mechanisms come into direct conflict when microbes compete with each other for this scarce resource in the environment and when pathogenic bacteria infect animal hosts. A very simple and potently effective strategy employed by many animals to ward off bacterial and fungal infections, at least in the early stages while pathogen-specific adaptive immune responses are developing, is to further constrict the already tightly controlled endogenous iron budget, starving invading microbial pathogens of needed iron. The complicated system of endogenous iron transport permits these changes in response to infection. However, in a countering response, successful pathogens have developed a variety of strategies to evade this defense, the simplest and most dramatic of which is perhaps exemplified by the spirochete Borrelia burgdorferi, the causative agent of Lyme disease, which has evolved away from the need for any iron whatsoever. Bacteria and protists have also developed sophisticated and complicated mechanisms to access heme-associated iron directly. However, other strategies developed by microbes to compete with each other for iron in the environment, mediated by small-molecule iron chelators called siderophores, are, in turn, useful to access the otherwise restricted pool of iron in transit in the body, carried as complexes with specific iron-binding proteins. To counter siderophore-mediated iron pilfering, animals have developed a panel of siderophore-specific binding proteins (siderocalins) to steal the iron (and siderophore) back. To subvert this counterstrategy, successful pathogenic bacteria modify their siderophores into stealthy forms that cannot bind to host siderocalins. As with any arms race (e.g., the process of evolution), the cycle of response/counterresponse is likely to continue ad infinitum.
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 44
IS  - S32
UR  - https://doi.org/10.1002/ppul.21133
DO  - doi:10.1002/ppul.21133
SP  - 213
EP  - 435
PY  - 2009
ER  - 

TY  - JOUR
TI  - Oral presentations
JO  - Journal of Thrombosis and Haemostasis
VL  - 7
IS  - s2
UR  - https://doi.org/10.1111/j.1538-7836.2009.03473_1.x
DO  - doi:10.1111/j.1538-7836.2009.03473_1.x
SP  - 1
EP  - 316
PY  - 2009
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Transplant International
VL  - 18
IS  - s1
UR  - https://doi.org/10.1111/j.1432-2277.2005.18s1_004.x
DO  - doi:10.1111/j.1432-2277.2005.18s1_004.x
SP  - 59
EP  - 249
PY  - 2005
ER  - 

TY  - JOUR
TI  - ESSR Abstracts 2009
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 96
IS  - S5
UR  - https://doi.org/10.1002/bjs.6650
DO  - doi:10.1002/bjs.6650
SP  - 1
EP  - 72
PY  - 2009
AB  - Abstract The 44th Congress of the European Society for Surgical Research takes place this year at Hôtel Atria, Nimes, France, 20?23 May 2009, under the presidency of Roland G. Demaria, MD, PhD, FETCS. To view the abstracts from this meeting, please click the pdf link on this page. Copyright ? 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
AU  - Ning, MingMing
AU  - Lopez, Mary
AU  - Cao, Jing
AU  - Buonanno, Ferdinando S.
AU  - Lo, Eng H.
TI  - Application of proteomics to cerebrovascular disease
JO  - ELECTROPHORESIS
JA  - ELECTROPHORESIS
VL  - 33
IS  - 24
UR  - https://doi.org/10.1002/elps.201200481
DO  - doi:10.1002/elps.201200481
SP  - 3582
EP  - 3597
KW  - Biomarker
KW  - Cerebrovascular disease
KW  - Cerebrospinal fluid (CSF)
KW  - Mass spectrometry
KW  - Pharmaco-proteomics
KW  - Stroke
PY  - 2012
AB  - While neurovascular diseases such as ischemic and hemorrhagic stroke are the leading causes of disability in the world, the repertoire of therapeutic interventions has remained remarkably limited. There is a dire need to develop new diagnostic, prognostic, and therapeutic options. The study of proteomics is particularly enticing for cerebrovascular diseases such as stroke, which most likely involve multiple gene interactions resulting in a wide range of clinical phenotypes. Currently, rapidly progressing neuroproteomic techniques have been employed in clinical and translational research to help identify biologically relevant pathways, to understand cerebrovascular pathophysiology, and to develop novel therapeutics and diagnostics. Future integration of proteomic with genomic, transcriptomic, and metabolomic studies will add new perspectives to better understand the complexities of neurovascular injury. Here, we review cerebrovascular proteomics research in both preclinical (animal, cell culture) and clinical (blood, urine, cerebrospinal fluid, microdialyates, tissue) studies. We will also discuss the rewards, challenges, and future directions for the application of proteomics technology to the study of various disease phenotypes. To capture the dynamic range of cerebrovascular injury and repair with a translational targeted and discovery approach, we emphasize the importance of complementing innovative proteomic technology with existing molecular biology models in preclinical studies, and the need to advance pharmacoproteomics to directly probe clinical physiology and gauge therapeutic efficacy at the bedside.
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - The FEBS Journal
VL  - 276
IS  - s1
UR  - https://doi.org/10.1111/j.1742-4658.2009.07049.x
DO  - doi:10.1111/j.1742-4658.2009.07049.x
SP  - 95
EP  - 356
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00020.x
DO  - doi:10.1111/j.1538-7836.2007.tb00020.x
SP  - P-M-501
EP  - P-M-701
PY  - 2007
ER  - 

TY  - JOUR
TI  - AASLD Abstracts
JO  - Hepatology
JA  - Hepatology
VL  - 56
IS  - S1
UR  - https://doi.org/10.1002/hep.26040
DO  - doi:10.1002/hep.26040
SP  - 191A
EP  - 1144A
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Stroke
VL  - 5
IS  - s2
UR  - https://doi.org/10.1111/j.1747-4949.2010.00480.x
DO  - doi:10.1111/j.1747-4949.2010.00480.x
SP  - 1
EP  - 375
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Diabetes Investigation
JA  - J Diabetes Investig
VL  - 10
IS  - S1
UR  - https://doi.org/10.1111/jdi.13033
DO  - doi:10.1111/jdi.13033
SP  - 24
EP  - 44
PY  - 2019
ER  - 

TY  - JOUR
TI  - American Transplant Congress 2007 Executive and Program Planning Committees and Abstract Review Committees
JO  - American Journal of Transplantation
VL  - 7
IS  - s2
UR  - https://doi.org/10.1111/j.1600-6143.2007.01811.x
DO  - doi:10.1111/j.1600-6143.2007.01811.x
SP  - 17
EP  - 584
PY  - 2007
ER  - 

TY  - JOUR
TI  - The International Liver Transplantation Society: 15th Annual International Congress
JO  - Liver Transplantation
JA  - Liver Transpl
VL  - 15
IS  - S7
UR  - https://doi.org/10.1002/lt.21830
DO  - doi:10.1002/lt.21830
SP  - S1
EP  - S299
PY  - 2009
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 16
IS  - S3
UR  - https://doi.org/10.1111/ajt.13898
DO  - doi:10.1111/ajt.13898
SP  - 405
EP  - 798
PY  - 2016
ER  - 

TY  - JOUR
TI  - EACS 2019 – Abstract Book
JO  - HIV Medicine
JA  - HIV Med
VL  - 20
IS  - S9
UR  - https://doi.org/10.1111/hiv.12814
DO  - doi:10.1111/hiv.12814
SP  - 3
EP  - 316
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts of papers submitted to the american association for the study of liver diseases
JO  - Hepatology
JA  - Hepatology
VL  - 18
IS  - S7
UR  - https://doi.org/10.1002/hep.1840180703
DO  - doi:10.1002/hep.1840180703
SP  - 57A
EP  - 346A
PY  - 1993
ER  - 

TY  - JOUR
TI  - Tissue Engineering and Regenerative Medicine
JO  - Journal of Tissue Engineering and Regenerative Medicine
VL  - 6
IS  - s1
UR  - https://doi.org/10.1002/term.1586
DO  - doi:10.1002/term.1586
SP  - 1
EP  - 429
PY  - 2012
ER  - 

TY  - JOUR
TI  - Tuesday, 1 September 2009 - Parallel Sessions 19-36
JO  - Transplant International
VL  - 22
IS  - s2
UR  - https://doi.org/10.1111/j.1432-2277.2009.00960.x
DO  - doi:10.1111/j.1432-2277.2009.00960.x
SP  - 45
EP  - 81
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts—Speakers
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Res
VL  - 41
IS  - S1
UR  - https://doi.org/10.1111/acer.13392
DO  - doi:10.1111/acer.13392
SP  - 265A
EP  - 338A
PY  - 2017
ER  - 

TY  - JOUR
TI  - ABSTRACTS FOR POSTERS
JO  - Obesity Research
JA  - Obesity Research
VL  - 11
UR  - https://doi.org/10.1002/j.1550-8528.2003.tb00016.x
DO  - doi:10.1002/j.1550-8528.2003.tb00016.x
SP  - A43
EP  - A152
PY  - 2003
ER  - 
